The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

Agree Realty Corporation

Related Interviews

Inflation Concerns, Economic Defensiveness Benefiting REITs
May 15, 2022
Gorman, Michael

REITs Performing Better After a Year of Significant Underperformance
August 10, 2018
Stevenson, Rob

A Bullish View on Apartments Subsector as Supply Diminishes
August 11, 2017
Stevenson, Rob

REIT Investor Base Broadens as Generalist Investors Enter the Sector
July 15, 2016
Stevenson, Rob

A Decreasing Risk Profile For The Reit Industry - Paul E. Adornato - Bmo Capital Markets
February 07, 2011

Cart

Latest News

Gilead (GILD) is a Biotech Bottom Buy According to Hartaj Singh of Oppenheimer & Company
Hitachi, Sony, Mitsubishi, Tokio Marine, and Keyence: a Japanese Stock Portfolio
Walmart (WMT) is an Undervalued Real Estate Play and So Is the New York Times (NYT)

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Interview with the Executive Chairman, Interim CEO and Chief Scientific Officer: RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI)

Arnold Lippa

Published August 18, 2022 in Biotechnology and Pharmaceuticals

Companies covered: RSPI

Buy ($25)

Interview with the Co-Founder, President and CEO: Equillium Inc. (NASDAQ:EQ)

Bruce Steel

Published August 18, 2022 in Biotechnology and Pharmaceuticals

Companies covered: EQ

Buy ($25)

Interview with the CEO: Adaptimmune Therapeutics PLC (NASDAQ:ADAP)

Adrian Rawcliffe

Published August 18, 2022 in Biotechnology and Pharmaceuticals

Companies covered: ADAP

Buy ($25)

Most Popular Reports

Biotechnology and Pharmaceuticals

Published August 18, 2022

Buy ($175)

Investing Strategies

Published August 04, 2022

Buy ($175)

Banks

Published August 01, 2022

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Bank of America Corporation
Exxon Mobil Corporation
Dell Inc.
Verizon Communications Inc.
AT&T Inc.

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the Executive Chairman, Interim CEO and Chief Scientific Officer: RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI)
Interview with the Co-Founder, President and CEO: Equillium Inc. (NASDAQ:EQ)
Interview with the CEO: Adaptimmune Therapeutics PLC (NASDAQ:ADAP)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Negative Consumer Sentiment Is Actually a Bullish Indicator
3 Great Companies Finally Cheap Enough to Buy
Creating a Platform That Lets Financial Advisers Do It Their Way
ANALYST INTERVIEWS
Innovative New Cell and Gene Therapies Show Transformative Benefits
Sizing Up Risk Across the Biotech Cap Spectrum
Biotechs Hit Bottom and Bounce Back — Twice
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2022
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google
Join now! | Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google